FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/059495 [Registered on: 03/11/2023] Trial Registered Prospectively
Last Modified On: 02/11/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   To find out the prevalence of Anxiety, Depressive symptoms and Substance use in persons with Schizophrenia. 
Scientific Title of Study   Prevalence of Anxiety, Depressive Symptoms and Substance Use in persons with Schizophrenia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Prabhas Pandey 
Designation  Post Graduate Junior Resident 
Affiliation  Government Medical College And Hospital Chandigarh 
Address  Department of Psychiatry, Block-D, Level-V Government Medical College and Hospital, Sector-32, Chandigarh (UT)

Chandigarh
CHANDIGARH
160030
India 
Phone  7898021558  
Fax    
Email  pandey.prabhas@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ajeet Sidana 
Designation  Professor 
Affiliation  Government Medical College and Hospital, Sector-32, Chandigarh 
Address  Department of Psychiatry, Block-D, Level-V Government Medical College and Hospital, Sector-32, Chandigarh (UT)

Chandigarh
CHANDIGARH
160030
India 
Phone  9056422679  
Fax  0172-2609360  
Email  ajeetsidana@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ajeet Sidana 
Designation  Professor 
Affiliation  Government Medical College and Hospital, Sector-32, Chandigarh  
Address  Department of Psychiatry, Block-D, Level-V Government Medical College and Hospital, Sector-32, Chandigarh (UT)

Chandigarh
CHANDIGARH
160030
India 
Phone  9056422679  
Fax  0172-2609360  
Email  ajeetsidana@hotmail.com  
 
Source of Monetary or Material Support  
Government Medical College and Hospital, Sector 32, Chandigarh 
 
Primary Sponsor  
Name  Government Medical College and Hospital 
Address  Sector 32, Chandigarh 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 3  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prabhas Pandey  IPD/ Psychiatry Ward  LEVEL 3, Government Medical College and Hospital, South Campus, Sector 48, Chandigarh
Chandigarh
CHANDIGARH 
7898021558

pandey.prabhas@yahoo.com 
Dr Prabhas Pandey  Mental Health Institute  OPD Room, Sector 32 C Chandigarh
Chandigarh
CHANDIGARH 
7898021558

pandey.prabhas@yahoo.com 
Dr Prabhas Pandey  OPD  Room No 4212, Level 4, B Block, Government Medical College and Hospital, Sector 32, Chandigarh
Chandigarh
CHANDIGARH 
7898021558

pandey.prabhas@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, GMCH Chandigarh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F20||Schizophrenia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Diagnosis of Schizophrenia according to ICD-11.
2. Age group 18- 60 years.
3. Any gender.
4. Duration of Illness less than 5
 
 
ExclusionCriteria 
Details  1. Individuals with intellectual disability, uncooperative and violent patient.
2. Patient’s not giving consent.
3. Actively Suicidal patients 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To estimate the Prevalence of Anxiety, Depressive symptoms and Substance use in persons with Schizophrenia.  Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the frequency & severity of Anxiety, Depressive symptoms & Substance Use in persons with Schizophrenia.  Baseline 
To find correlation among Anxiety, Depressive symptoms & Substance Use with severity of Schizophrenia.  Baseline 
 
Target Sample Size   Total Sample Size="170"
Sample Size from India="170" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

A total of 170 consecutive patients diagnosed with Schizophrenia as per ICD-11 coming to follow up in OPD and admitted in IPD will be evaluated based upon the inclusion and exclusion criteria mentioned above. Patients will be enrolled in the study after obtaining informed consent from the patient.

Vitals with Routine Investigations (CBC, SERFT, LFT, LIPID PROFILE, FBS) along with

ECG will be done at baseline.

PANSS will be applied to all those individuals

AIMS Scale will be applied for EPS

In all patients HAM-A will be applied for Anxiety symptoms

HAM-D will be applied for Depressive symptoms

ASSIT will be applied for Substance Use

Data will be compiled on excel sheet and will be analysed using SPSS.

After assessment of these symptoms, same will be communicated to the Treating Psychiatrist.

 
Close